bexmarilimab
FDA, Finnish Medicines Agency Approve Initiation of Phase I/II Study of Bexmarilimab
Kerri FitzgeraldAcute Myeloid Leukemia | February 2, 2023
The FDA and Finnish Medicines Agency cleared the investigational new drug application for bexmarilimab.
Read More
FDA OKs Study of Bexmarilimab in AML/MDS/CML
Leah LawrenceChronic Myeloid Leukemia | February 2, 2023
The phase I/II study will assess the safety and tolerability of the drug.
Read More
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |